[Results of the surgical treatment of metastatic XXXX ].

@entity1 @entity2657 @entity1313 @entity75 @entity5 @entity16 @entity428 @entity3 @entity204
Results of surgical treatment in 85 cases with metastatic @entity1313 are reviewed. The lung was the most frequent site of @entity75 and the following sites were GI tract and the breast. Adequate treatment consisted of total removal of @entity5 , irradiation and/or chemotherapy were carried out in 51 cases. The remaining 34 cases had an unsuccessful treatment because of their poor physical condition. Mean survival time after adequate treatment was 8.75 months in the former group and 3.06 months in the latter group. Of 51 @entity1 (86.3%) in the former group, 44 showed improvement of the neurological signs after treatment. In the latter group, only 14 @entity1 (41.2%) revealed @entity16 . @entity5 was carried out in 55 of 85 cases. The one-month operative mortality for all @entity1 was 19.2%. Postoperative one-year survival rate was 12.5% in 16 cases with multiple @entity3 and in 36 cases with single @entity3 was 25.6%. Follow-up study of 77 cases showed 31.2% of survival rate in 6 months, 18.2% in one-year and 5.2% in two-years. Only four @entity1 survived more than 3 years after treatment. The direct causes of @entity204 in cases of total removal were attributed in recurrence of @entity75 or remote @entity3 to other organs. This study revealed that the prognosis of the @entity1 with metastatic @entity1313 was influenced by existence of @entity428 due to @entity2657 or @entity3 itself and @entity3 to other organs.(ABSTRACT TRUNCATED AT 250 WORDS)
